A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)
Public ClinicalTrials.gov record NCT06333860. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4 Multicenter, Randomized, Open-label, Efficacy Assessor Blinded Study of Risankizumab Compared to Deucravacitinib for the Treatment of Adult Subjects With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy
Study identification
- NCT ID
- NCT06333860
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 393 participants
Conditions and interventions
Conditions
Interventions
- Deucravacitinib Drug
- Risankizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 9, 2024
- Primary completion
- Mar 18, 2026
- Completion
- Mar 18, 2026
- Last update posted
- Apr 14, 2026
2024 – 2026
United States locations
- U.S. sites
- 39
- U.S. states
- 18
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Total Skin and Beauty Dermatology Center /ID# 263011 | Birmingham | Alabama | 35205 | — |
| Advanced Research Associates - Glendale /ID# 263621 | Glendale | Arizona | 85308 | — |
| Clear Dermatology & Aesthetics Center /ID# 263626 | Scottsdale | Arizona | 85260 | — |
| Dermatology Trial Associates /ID# 264480 | Bryant | Arkansas | 72022 | — |
| First OC Dermatology /ID# 263003 | Fountain Valley | California | 92708 | — |
| Integrative Skin Science and Research /ID# 264504 | Sacramento | California | 95815 | — |
| Physioseq, LLC /ID# 265035 | Sacramento | California | 95825 | — |
| Medderm Associates Dermatology /ID# 263858 | San Diego | California | 92103 | — |
| Southern California Dermatology /ID# 263021 | Santa Ana | California | 92701 | — |
| Clearlyderm Dermatology - West Boca /ID# 264963 | Boca Raton | Florida | 33428 | — |
| Driven Research /ID# 263002 | Coral Gables | Florida | 33134 | — |
| Skin Care Research - Hollywood /ID# 263877 | Hollywood | Florida | 33021-6748 | — |
| International Dermatology Research /ID# 264911 | Miami | Florida | 33144 | — |
| Lenus Research and Medical Group /ID# 263886 | Miami | Florida | 33172 | — |
| Wellness Clinical Research - Miami Lakes /ID# 263887 | Miami Lakes | Florida | 33016 | — |
| Skin Care Research - Tampa /ID# 263880 | Tampa | Florida | 33607-6438 | — |
| Advanced Clinical Research Institute /ID# 263878 | Tampa | Florida | 33607 | — |
| University Dermatology and Vein Clinic, LLC /ID# 263028 | Chicago | Illinois | 60640-7972 | — |
| Arlington Dermatology /ID# 263001 | Rolling Meadows | Illinois | 60008 | — |
| Dawes Fretzin, LLC /ID# 264578 | Indianapolis | Indiana | 46256 | — |
| MetroBoston Clinical Partners /ID# 263860 | Boston | Massachusetts | 02135-3511 | — |
| University of Michigan Health System - Ann Arbor /ID# 265233 | Ann Arbor | Michigan | 48109 | — |
| Clinical Research Institute of Michigan - Clinton Township Office /ID# 264968 | Clinton Township | Michigan | 48038 | — |
| Dermatology and Skin Center of Lees Summit /ID# 263560 | Lee's Summit | Missouri | 64064-2301 | — |
| Physician Research Collaboration, LLC /ID# 263568 | Lincoln | Nebraska | 68516 | — |
| Skin Cancer and Dermatology Institute - Reno /ID# 263697 | Reno | Nevada | 89509 | — |
| StracSkin, PLLC /ID# 263024 | Portsmouth | New Hampshire | 03801 | — |
| Oregon Dermatology & Research Center /ID# 263674 | Portland | Oregon | 97210 | — |
| Clinical Partners /ID# 263862 | Johnston | Rhode Island | 02919 | — |
| Health Concepts /ID# 263016 | Rapid City | South Dakota | 57702 | — |
| Arlington Research Center, Inc /ID# 263908 | Arlington | Texas | 76011 | — |
| Bellaire Dermatology Associates /ID# 263897 | Bellaire | Texas | 77401 | — |
| U.S. Dermatology Partners - Cedar Park /ID# 263906 | Cedar Park | Texas | 78613 | — |
| Dermatology Treatment and Research Center /ID# 267071 | Dallas | Texas | 75230 | — |
| Texas Dermatology Research Center /ID# 264487 | Plano | Texas | 75025 | — |
| Dermatology Clinical Research Center of San Antonio /ID# 263869 | San Antonio | Texas | 78229 | — |
| Center for Clinical Studies - Clear Lake /ID# 263009 | Webster | Texas | 77598 | — |
| Center for Clinical Studies - Clear Lake /ID# 263917 | Webster | Texas | 77598 | — |
| Premier Clinical Research /ID# 263679 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06333860, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06333860 live on ClinicalTrials.gov.